Dolby Laboratories (DLB) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue was $288.8M, down 3% year-over-year but above the midpoint of guidance; non-GAAP EPS was $0.71, above the high end of guidance, with GAAP net income at $38.4M, up from $16.4M in Q3 2023.

• Licensing remains the primary revenue driver, accounting for 92% of total revenue.

• Dolby Atmos and Dolby Vision outperformed expectations, with strong content growth and device attach rates, while foundational audio and cinema products underperformed.

• Pending acquisition of GE Licensing for $429M and THEO Technologies for $55–$58M to expand imaging patents and enhance Dolby.io.

• Cash and investments totaled $1.1B at quarter end, supporting operations and capital allocation.

Financial highlights

• Q3 2024 revenue was $288.8M, down 3% year-over-year; licensing revenue was $267.1M, down 2%; products and services revenue was $22M, down 14%.

• Net income attributable to Dolby was $38.4M, up from $16.4M in Q3 2023; diluted EPS was $0.40 vs. $0.17.

• Gross margin was approximately 88%, with licensing gross margin at 94% and products/services at 16%.

• Operating income rose to $36.8M from $15.9M year-over-year, aided by lower operating expenses and restructuring charges.

• Cash flow from operations for the nine months ended June 28, 2024 was $211.1M, down from $282.1M year-over-year.

Outlook and guidance

• Q4 2024 revenue expected between $300M–$320M; licensing revenue $275M–$295M.

• Q4 non-GAAP gross margin projected at 88%; non-GAAP operating expenses between $190M and $200M.

• Q4 non-GAAP EPS expected between $0.61 and $0.76; full-year revenue guidance narrowed to $1.27B–$1.29B, with non-GAAP EPS of $3.60–$3.75.

• Full-year GAAP EPS expected at $2.40–$2.55; non-GAAP operating margin for FY24 expected at ~31%.

• Restructuring actions in 2024 expected to yield $3M in pre-tax operating income savings in FY24 and $11M in FY25.